The Relation of Patients' Treatment Preferences to Outcome in a Randomized Clinical Trial

Behavior Therapy

Volumn 38, Issue 3, 2007, Pages 209-217

  Leykin, Yan ^a,b,c,d   DeRubeis, Robert J ^a,b,c,d   Gallop, Robert ^a,b,c,d   Amsterdam, Jay D ^a,b,c,d   Shelton, Richard C ^a,b,c,d   Hollon, Steven D ^a,b,c,d  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b WEST CHESTER UNIVERSITY   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTPATIENT CARE; PATIENT CARE; PATIENT CARE PLANNING; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; TREATMENT PLANNING; TREATMENT RESPONSE;

ADULT; CHOICE BEHAVIOR; COGNITIVE THERAPY; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT SATISFACTION; PLACEBO EFFECT; RESEARCH DESIGN; SEX FACTORS;

EID: 34547657951     PISSN: 00057894     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.beth.2006.08.002     Document Type: Article

References (22)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. (1994), Author, Washington, DC
2. Beck A.T., Steer R.A., and Brown G.K. BDI-II Manual (1996), The Psychological Corporation, San Antonio, TX
3. Braver S.L., and Smith M.C. Maximizing both external and internal validity in longitudinal true experiments with voluntary treatments: The combined modified design. Evaluation and Program Planning 19 (1996) 287-300
4. Brewin C.R., and Bradley C. Patient preferences and randomised clinical trials. British Medical Journal 299 (1989) 313-315
5. Chilvers C., Dewey M., Fielding K., Gretton V., Miller P., Palmer B., Weller D., Churchill R., Williams I., Bedi N., Duggan C., Lee A., Harrison G., and For the Counseling Versus Antidepressants in Primary Care Study Group. Antidepressant drugs and generic counseling for treatment of major depression in primary care: randomized trial with patient preference arms. British Medical Journal 322 (2001) 772-775
6. Corrigan P.W., and Salzer M.S. The conflict between random assignment and treatment preference: Implications for internal validity. Evaluation and Program Planning 26 (2003) 109-121
7. DeRubeis R.J., Hollon S.D., Amsterdam J.D., Shelton R.C., Young P.R., Salomon R.M., O'Reardon J.P., Lovett M.L., Gladis M.M., Brown L.L., and Gallop R. Cognitive therapy vs medications in the treatment of moderate to severe depression. Archives of General Psychiatry 62 (2005) 409-416
8. Devine D.A., and Fernald P.S. Outcome effects of receiving a preferred, randomly assigned, or nonpreferred therapy. Journal of Consulting and Clinical Psychology 41 (1973) 104-107
9. First M.B., Spitzer R.L., Miriam G., and Williams J.B.W. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition (SCID-I/P) (2001), Biometrics Research, New York State Psychiatric Institute, New York
10. Franklin M.E., Abramowitz J.S., Kozak M.J., Levitt J.T., and Foa E.B. Effectiveness of exposure and ritual prevention for obsessive-compulsive disorder: Randomized compared with nonrandomized samples. Journal of Consulting and Clinical Psychology 68 (2000) 594-602
11. Hamilton M. A rating scale for depression. Journal of Neurology Neurosurgery and Psychiatry 23 (1960) 56-62
12. Juster H.R., Heimberg R.G., and Engelberg B. Self-selection and sample selection in a treatment study of social phobia. Behaviour Research and Therapy 33 (1995) 321-324
13. King M., Nazareth I., Lampe F., Bower P., Chandler M., Morou M., Sibbald B., and Lai R. Impact of participant and physician intervention preferences on randomized trials: A systematic review. Journal of the American Medical Association 293 (2005) 1089-1099
14. Leykin, Y., DeRubeis, R.J., Shelton, R.C., & Amsterdam, J.D. (In press). Changes in patients' beliefs about the causes of their depression following successful treatment. Cognitive Therapy and Research.
15. Reimherr F.W., Amsterdam J.D., Quitkin F.M., Rosenbaum J.F., Fava M., Zajecka J., Beasley C.M., Michelson D., Roback P., and Sundell K. Optimal length of continuation therapy in depression: A prospective assessment during long-term fluoxetine treatment. American Journal of Psychiatry 155 (1998) 1247-1253
16. Renjilian D.A., Perri M.G., Nezu A.M., McKelvey W.F., Shermer R.L., and Anton S.D. Individual versus group therapy for obesity: Effects of matching participants to their treatment preferences. Journal of Consulting and Clinical Psychology 69 (2001) 717-721
17. Seligman M.E. Learned optimism (1991), Knopf, New York
18. Seligman M.E. The effectiveness of psychotherapy. The Consumer Reports study. American Psychologist 50 (1995) 965-974
19. Silverman W.A., and Altman D.G. Patients' preferences and randomised trials. Lancet 347 (1996) 171-174
20. Stirman S.W., DeRubeis R.J., Crits-Christoph P., and Brody P.E. Are samples in randomized controlled trials of psychotherapy representative of community outpatients? A new methodology and initial findings. Journal of Consulting and Clinical Psychology 71 (2003) 963-972
21. Stirman S.W., DeRubeis R.J., Crits-Christoph P., and Rothman A. Can the randomized controlled trial literature generalize to nonrandomized patients?. Journal of Consulting and Clinical Psychology 73 (2005) 127-135
22. Van Dyck R., and Spinhoven P. Does preference for type of treatment? A study of exposure in vivo with or without hypnosis in the treatment of panic disorder with agoraphobia. Behavior Modification 21 (1997) 172-186